Filling the hole: evidence of a small molecule binding to the fusion core pocket in human respiratory syncytial virus

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.2, 2005-02, pp. : 195-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Respiratory syncytial virus antiviral agents

By Prince G.A.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 753-762

Informa Healthcare

Access to resources Recommend Favorite

Development of respiratory syncytial virus vaccines

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The development of antiviral therapy and vaccines against respiratory syncytial virus and human parainfluenza virus type 3

By A J.E.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite

Impact of Respiratory Syncytial Virus: The Nurse's Perspective

By Bracht Marianne

Drugs in R&D, Vol. 11, Iss. 3, 2011-09 ,pp. : 215-226

Adis International

Access to resources Recommend Favorite

Emerging drugs for respiratory syncytial virus infection

By Olszewska Wieslawa Openshaw Peter

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite